Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice

被引:5
作者
Guo, Hangyuan [1 ]
Xu, Fukang [1 ]
Sun, Aijing [1 ]
Liu, Longbin [1 ]
Shi, Yafei [1 ]
机构
[1] Shaoxing Peoples Hosp, Dept Cardiol, Shaoxing 312000, Zhejiang, Peoples R China
关键词
atherosclerosis; heparin; homocysteine; matrix metalloproteinase; SMOOTH-MUSCLE-CELLS; PROTEIN-TYROSINE PHOSPHORYLATION; GROWTH-FACTOR; PROLIFERATION; CHOLESTEROL; EXPRESSION; MIGRATION; INVASION; ANGIOGENESIS; HOMOCYSTEINE;
D O I
10.1097/MCA.0b013e328333f53b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study aimed to find the effects of heparin on atherosclerosis and the production of matrix metalloproteinase (MMP)-2 in low-density lipoprotein receptor-deficient (LDLr-/-) mice. Methods Sixteen 7-week-old LDLr-/- mice were randomized to receive sterile water or heparin. The levels of total cholesterol, high-density lipoprotein cholesterol, triglyceride and homocysteine were measured. Mean lesions area was calculated as the total atherosclerotic lesions area and expressed as a percentage of total luminal surface area. The lesions area was measured blindly by the same person using computer-assisted image analysis. The expression and localization of the MMP-2 was examined by immunohistochemistry. Results All mice exhibited atherosclerotic lesions in the aortic sinus and aortic surface. Total cholesterol was decreased, while high-density lipoprotein cholesterol was increased in heparin compared with that in control group (P = 0.001 and 0.002). Triglyceride was not significantly different between the two groups (P = 0.92). The amount of atherosclerotic lesions in the aortic surface was 40.5% lower in heparin group than that in the control group P<0.001). The mean area of atherosclerotic lesions in the aortic sinus was also less in the heparin group than that in the control group. Coincidently, the expression of MMP-2 in the atherosclerotic lesions in the heparin group was 49.3% lower than that in the control group (P<0.001). Conclusion Heparin can inhibit the production of MMP-2 in the atherosclerotic lesions and improve the atherosclerotic lesions in LDLr-/- mice. Coron Artery Dis 21:39-45 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 39 条
[1]   Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives [J].
Beaudeux, JL ;
Giral, P ;
Bruckert, E ;
Foglietti, MJ ;
Chapman, MJ .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (02) :121-131
[2]   Matrix metalloproteinases participate in osteosarcoma invasion [J].
Bjornland, K ;
Flatmark, K ;
Pettersen, S ;
Aaasen, AO ;
Fodstad, O ;
Maelandsmo, GM .
JOURNAL OF SURGICAL RESEARCH, 2005, 127 (02) :151-156
[3]   Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells [J].
Bono, F ;
Rigon, P ;
Lamarche, I ;
Savi, P ;
Salel, V ;
Herbert, JM .
BIOCHEMICAL JOURNAL, 1997, 326 :661-668
[4]   IDENTIFICATION OF 92-KD GELATINASE IN HUMAN CORONARY ATHEROSCLEROTIC LESIONS - ASSOCIATION OF ACTIVE ENZYME-SYNTHESIS WITH UNSTABLE ANGINA [J].
BROWN, DL ;
HIBBS, MS ;
KEARNEY, M ;
LOUSHIN, C ;
ISNER, JM .
CIRCULATION, 1995, 91 (08) :2125-2131
[5]   Effect of glucose and heparin on mesangial alpha 1(IV)COLL and MMP-2/TIMP-2 mRNA expression [J].
Caenazzo, C ;
Garbisa, S ;
Onisto, M ;
Zampieri, M ;
Baggio, B ;
Gambaro, G .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (03) :443-448
[6]   Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis - Studies with the combined use of rosuvastatin and candesartan [J].
Chen, JW ;
Li, DY ;
Schaefer, R ;
Mehta, JL .
ATHEROSCLEROSIS, 2006, 184 (02) :295-301
[7]  
Corbelli John C, 2003, Crit Pathw Cardiol, V2, P71, DOI 10.1097/01.hpc.0000076944.89977.38
[8]   MATRIX METALLOPROTEINASES AND CARDIOVASCULAR-DISEASE [J].
DOLLERY, CM ;
MCEWAN, JR ;
HENNEY, AM .
CIRCULATION RESEARCH, 1995, 77 (05) :863-868
[9]   A CONTROLLED STUDY OF THE EFFECT OF INTERMITTENT HEPARIN THERAPY ON THE COURSE OF HUMAN CORONARY ATHEROSCLEROSIS [J].
ENGELBERG, H ;
KUHN, R ;
STEINMAN, M .
CIRCULATION, 1956, 13 (04) :489-498
[10]   HEPARIN AND ATHEROSCLEROSIS - REVIEW OF OLD AND RECENT FINDINGS [J].
ENGELBERG, H .
AMERICAN HEART JOURNAL, 1980, 99 (03) :359-372